Itolizumab monoclonal antibody in the COVID-19 battle
Novel drug developed at Cuba’s Center for Molecular Immunology for the treatment of lymphomas and leukemia, now being used with COVID-19 patients
46 resultados.
Novel drug developed at Cuba’s Center for Molecular Immunology for the treatment of lymphomas and leukemia, now being used with COVID-19 patients
Cuban women are on the front lines of the COVID-19 battle, participating in the development of new treatment protocols, conducting critical research, and leading clinical trials of four candidate vaccines
After several months of research, a multidisciplinary team of scientists has released new information about the devastating tornado that struck five Havana municipalities, January 27, this year
In addition to its proven effectiveness and safety, it is inexpensive and easy to use
Just months after Cuba detected its first positive case of COVID-19, the country already had a specific vaccine candidate—exactly five years ago today
Forecasts indicate that some 15 named storms can expected in the region, while the probability of the island being hit by at least one hurricane is 60%
A memorandum of understanding will be signed soon, with the purpose of inserting the science, technology and innovation entities of our country in the initiative of the Chinese government for the development of the Belt and Road
The 15th International Convention on Environment and Development is taking place at the Convention Palace until July 5
“Science, like all culture, will continue to be the nation’s shield and sword”
Studies published in scientific journals since the beginning of the new coronavirus pandemic suggest the existence of individual genetic factors that may be related to the development of severe symptoms in certain COVID-19 patients